Core Viewpoint - *ST Suwu has been identified for continuous financial fraud over four years, leading to potential mandatory delisting due to significant violations of regulations [1][3]. Summary by Sections Financial Misconduct - From 2020 to 2023, *ST Suwu reported false financial statements, inflating revenue by 4.95 billion, 4.69 billion, 4.31 billion, and 3.77 billion respectively, which accounted for 26.46%, 26.39%, 21.26%, and 16.82% of the reported revenue for those years [2]. - The company also inflated total profits by 145.83 million, 202.71 million, 199.24 million, and 212.19 million, representing 2.89%, 51.65%, 26.42%, and 29.81% of the total profits for the respective years [2]. - Non-operational fund occupation by related parties was not disclosed, with balances of 127 million, 1.393 billion, 1.543 billion, and 1.693 billion, which constituted 6.88%, 74.20%, 84.60%, and 96.09% of the net assets [2]. Control and Reporting Issues - The actual controller of *ST Suwu was misreported in annual reports from 2018 to 2023, with the company incorrectly identifying Qian Qunying as the actual controller instead of Qian Qunshan [3]. Regulatory Actions and Consequences - Starting July 14, *ST Suwu's stock will be subject to delisting risk warnings due to the serious violations identified [3]. - During the delisting risk warning period, the company must disclose progress every five trading days and provide special risk warnings regarding the potential for mandatory delisting [4]. - The company has a history of warnings about delisting risks, with the China Securities Regulatory Commission (CSRC) issuing a notice of investigation in February 2023 [4]. Future Implications - The CSRC maintains a strict stance on delisting, indicating that even if a company is delisted, it remains accountable for any illegal activities [5]. - Investors may pursue civil compensation for false statements after the final administrative penalty decision is made [5]. - The Supreme People's Court and CSRC have issued guidelines to enhance investor protection and combat fraudulent activities in the capital market [5].

Core Viewpoint - *ST Suwu has been identified for continuous financial fraud over four years, leading to a significant violation that may result in mandatory delisting from the stock market [2][4]. Financial Misconduct - The company has been found to have inflated revenue and profit figures from 2020 to 2023, with inflated revenues of 4.95 billion, 4.69 billion, 4.31 billion, and 3.77 billion respectively, representing 26.46%, 26.39%, 21.26%, and 16.82% of the reported revenues for those years [2][3]. - The inflated profit totals for the same period were 145.83 million, 202.71 million, 199.24 million, and 212.19 million, accounting for 2.89%, 51.65%, 26.42%, and 29.81% of the reported profits [2][3]. Non-Disclosure of Related Party Transactions - The company failed to disclose significant non-operating fund occupations by related parties, with balances of 127 million, 1.393 billion, 1.543 billion, and 1.693 billion from 2020 to 2023, which constituted 6.88%, 74.20%, 84.60%, and 96.09% of the net assets reported [3]. Regulatory Actions and Consequences - Following the identification of these violations, *ST Suwu is subject to a fine of 10 million and faces mandatory delisting as per the stock exchange regulations [2][4]. - The company must disclose updates on its situation every five trading days during the delisting risk warning period, and its stock will be suspended pending the final delisting decision [4]. Investor Protection and Legal Accountability - The China Securities Regulatory Commission (CSRC) emphasizes that companies facing delisting will still be held accountable for their illegal activities, ensuring that investors can pursue civil compensation for false statements [5][6]. - The CSRC's approach includes strict enforcement of repayment obligations for fund occupations and a commitment to investor protection through legal frameworks [6].

Core Viewpoint - Tianmao Group, once a prominent player in the market, is facing delisting risks due to financial reporting issues and declining performance [1][4][9]. Financial Reporting Issues - Tianmao Group has been unable to release its financial reports on time, leading to a risk warning and subsequent stock suspension [3][4]. - The company announced on April 28 that it could not disclose its 2024 annual report and 2025 Q1 report by the scheduled date due to incomplete information [3]. - As of July 8, the stock was officially marked with a delisting risk warning, and the stock name changed to "*ST Tianmao" [2][4]. Performance Decline - In 2023, Tianmao Group reported a revenue of 49.699 billion yuan, a slight increase of 0.17% year-on-year, but a net loss of 0.652 billion yuan, reversing from a profit of 0.274 billion yuan in 2022 [5]. - The 2024 Q3 report indicated a revenue drop of 18.43% year-on-year, with a net loss of 0.333 billion yuan [5]. - The company projected a revenue of 40-43 billion yuan for 2024, down from 49.699 billion yuan in 2023, with expected losses between 0.5 billion and 0.75 billion yuan [5]. Core Asset and Business Structure - Tianmao Group's core asset is Guohua Life Insurance, which has been a significant contributor to its profits since 2014 [6]. - Guohua Life reported a net loss of 1.155 billion yuan in 2023, marking a turning point for the company [7]. - The insurance business faced challenges due to low interest rates, leading to increased reserve provisions [8]. Market Reactions and Future Outlook - Following the stock's resumption of trading on July 8, the share price continued to decline, closing at 2.23 yuan per share on July 11 [10]. - The company is committed to completing its financial reports and improving communication with stakeholders [11].

*ST紫天（300280）公告，公司因财务会计报告存在虚假记载，收到福建证监局责令改正决定书。公司 需在收到决定书之日起30日内更正年度报告并经会计师事务所全面审计。截至目前，公司尚未聘请具备 证券、期货相关业务资格的会计师事务所，也未向福建证监局提交整改报告。根据相关规定，公司股票 自2025年5月20日起被实施退市风险警示，并将于2025年7月19日前可能被终止上市。 ...

Core Viewpoint - The regulatory environment in the capital market remains stringent, with nearly 40 listed companies and over 20 responsible individuals being investigated in the first half of the year, primarily for information disclosure violations [1][3]. Group 1: Regulatory Actions - The China Securities Regulatory Commission (CSRC) has initiated investigations against several A-share companies, including Yangmei Chemical and Qing Shui Yuan, mainly for information disclosure violations, false annual report records, and failure to disclose periodic reports on time [1][3]. - More than 80% of the companies investigated this year have been found to have information disclosure violations [3]. - Some companies, even after delisting, continue to face regulatory penalties for past violations, such as *ST Hongtao, which was investigated for information disclosure violations after its delisting [1][10]. Group 2: Financial Performance of Investigated Companies - Many companies under investigation have reported consecutive years of losses and are entangled in lawsuits. For instance, Jiaao Environmental Protection has incurred losses of over 400 million yuan from 2022 to 2024, with a debt ratio exceeding 80% [10]. - Huayang United reported cumulative losses exceeding 1.8 billion yuan from 2022 to 2024 [10]. - Companies like Meichen Technology are facing multiple lawsuits, with new cases involving approximately 993,690 yuan, representing 9.72% of the company's latest audited net assets [10]. Group 3: Implications for Investors - The increasing number of investigations and penalties against companies, especially those at risk of delisting, raises concerns for investors, as these companies may face legal actions and claims from investors [11]. - Legal challenges in claiming compensation from delisted companies are significant, particularly when defendants are in operational distress [11]. - Regulatory authorities are urged to enhance management of delisted companies to ensure they maintain normal operations and comply with information disclosure requirements [11].

Group 1 - The company Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (*ST Suwu, stock code: 600200) has been investigated by the China Securities Regulatory Commission (CSRC), which may lead to a forced delisting if major violations are confirmed [1] - The company faces financial delisting risks due to its 2024 financial report receiving a disclaimer of opinion from the auditing firm, triggering delisting risk warnings from the Shanghai Stock Exchange [2] - The company's financial situation is deteriorating, with declining revenue and profits, and increasing debt pressure, indicating serious financial distress [2] Group 2 - A significant issue arose when the chairman of the company's wholly-owned subsidiary was criminally charged for fraudulently obtaining export tax rebates, highlighting internal management and compliance failures [2] - This criminal case could severely damage the company's reputation and creditworthiness, impacting its business expansion and financing capabilities [2] - Investors who purchased shares before February 26, 2025, and sold or still hold them as of February 27, 2025, may be eligible for compensation, pending court validation [3]

Core Viewpoint - *ST Yuancheng has been placed under investigation by the China Securities Regulatory Commission (CSRC) for suspected false disclosures in its annual reports and other periodic financial statements, which may lead to a forced delisting if significant violations are confirmed [1][10]. Financial Performance - The company has experienced a significant decline in revenue and net profit from 2020 to 2024, with revenues dropping from 5.97 billion yuan in 2020 to 1.46 billion yuan in 2024, and net profits turning from a profit of 925.31 million yuan in 2020 to a loss of 3.25 billion yuan in 2024 [5]. - In Q1 2024, the company reported revenues of 36.01 million yuan, a year-on-year increase of 25.34%, but the net loss expanded to 25.32 million yuan compared to a loss of 22.46 million yuan in the same period last year [6]. Regulatory Issues - The company has faced multiple regulatory warnings and has been under scrutiny for discrepancies in its financial reporting, including a significant error in the reported revenue for Q4 2024, which was later corrected [7]. - The actual controller and major shareholder, Zhu Changren, has also been implicated in failing to disclose shareholding changes and other related issues [8]. Delisting Risks - The company is at high risk of delisting due to potential violations of financial reporting regulations, with its stock already under risk warning since May 6, 2024, due to financial indicators that meet the criteria for mandatory delisting [10][11]. - As of July 2, 2023, 23 companies have been identified as facing delisting, with *ST Yuancheng being one of them due to significant violations and financial issues [10].

ST新潮（600777）公告，因定期报告涉及的部分财务信息需要进一步补充提供，公司无法在法定期限 内披露2024年年度报告及2025年第一季度报告。根据《上海证券交易所股票上市规则》，公司股票自 2025年5月6日起停牌。如公司在股票停牌两个月内仍未披露2024年年度报告，将被实施退市风险警示并 复牌。如公司股票交易被实施退市风险警示之日起的两个月内仍未披露过半数董事保证真实、准确、完 整的2024年年度报告，公司股票存在被上海证券交易所决定终止上市的风险。 ...

Core Viewpoint - *ST Yuancheng is facing severe financial and regulatory challenges, including potential delisting due to false financial disclosures and continuous operating losses [1][13][14]. Financial Performance - The company has experienced a significant decline in revenue and net profit from 2020 to 2024, with revenues dropping from 5.97 billion yuan in 2020 to 1.46 billion yuan in 2024, and net profits turning from a profit of 925.31 million yuan in 2020 to a loss of 325.26 million yuan in 2024 [7]. - In Q1 2024, the company reported a revenue of 36.01 million yuan, a year-on-year increase of 25.34%, but the net loss expanded to 25.32 million yuan compared to a loss of 22.46 million yuan in the same period last year [8]. Regulatory Issues - The company received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into false disclosures in its annual reports, which could lead to mandatory delisting if found guilty [1][13]. - The company has a history of regulatory warnings, including a recent warning from the Zhejiang Securities Regulatory Bureau for inaccuracies in financial disclosures [9][10]. Delisting Risks - *ST Yuancheng's stock has been placed under delisting risk warnings due to financial indicators that meet the criteria for mandatory delisting as per the stock listing rules [14]. - As of July 2, 2023, there are 23 companies facing delisting, with *ST Yuancheng being one of them due to both major violations and financial issues [15][16].

Core Viewpoint - *ST Yuancheng is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false disclosure of financial data in its annual reports and other periodic reports [2][5]. Financial Performance - *ST Yuancheng has reported continuous losses for the past three years, raising concerns about its ability to continue as a going concern and exposing it to financial delisting risks [6][8]. - The company's audited operating revenue for 2024 was 146 million yuan, with a net profit attributable to shareholders of the listed company (after deducting non-recurring gains and losses) amounting to -323 million yuan [9]. Regulatory Actions - The CSRC has initiated an investigation based on violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [2]. - If the CSRC's administrative penalties confirm significant violations, *ST Yuancheng's stock may face mandatory delisting under the Shanghai Stock Exchange's listing rules [5]. Debt and Receivables - As of December 31, 2024, *ST Yuancheng reported accounts receivable and contract assets totaling 684 million yuan, with significant amounts owed by its subsidiaries facing financial difficulties and litigation [10]. - The company is experiencing weak short-term solvency, with overdue bank loans and increasing litigation, indicating challenges in debt repayment [10]. Market Position - As of July 1, the stock price of *ST Yuancheng was 3.54 yuan per share, with a total market capitalization of 1.2 billion yuan [11].